Total nonsense.
The PEA was from 2023 and was based on a weighted average spodumene concentrate price of US$1,699t/CIF SC5.5 and US$927t/CIF SC3.
The DFS will be made at a time when Lithium prices are way lower.
I doubt they'll even use Lithium prices which are 50% of those used in the PEA.
So the NPV will be substantially lower than in the PEA.
- Forums
- Charts
- LRS General Discussion
Total nonsense. The PEA was from 2023 and was based on a...
Featured News
Add LRS (ASX) to my watchlist
|
|||||
Last
11.0¢ |
Change
-0.015(12.0%) |
Mkt cap ! $307.9M |
Open | High | Low | Value | Volume |
12.5¢ | 12.8¢ | 11.0¢ | $2.015M | 17.61M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 2510377 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 491254 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 2425377 | 0.110 |
20 | 2344002 | 0.105 |
46 | 2603359 | 0.100 |
1 | 8060 | 0.099 |
1 | 50000 | 0.098 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 491254 | 8 |
0.120 | 1361659 | 8 |
0.125 | 1725305 | 15 |
0.130 | 764464 | 11 |
0.135 | 851838 | 13 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
LRS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online